2 citations
,
April 2023 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.
2 citations
,
April 2021 in “Canadian Journal of Urology” Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.
2 citations
,
October 2020 in “Journal of Pharmacy And Bioallied Sciences” Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.
2 citations
,
August 2017 in “Dermatologic Therapy” Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.
2 citations
,
May 2010 in “Actas Dermo-Sifiliográficas” Home-use medical-cosmetic devices like lasers for hair removal may be convenient but need more research to confirm safety and effectiveness.
1 citations
,
February 2024 in “International Journal of Pharmacognosy & Chinese Medicine” Hibiscus rosa-sinensis Linn. has many medicinal benefits and needs proper identification for effective use.
1 citations
,
July 2023 in “Cureus” Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.
1 citations
,
January 2021 in “European journal of medical and health sciences” PRP shows promise for treating hair loss, but more research is needed.
1 citations
,
January 2021 in “Journal of Cutaneous and Aesthetic Surgery” Low-level light therapy can safely and effectively stimulate hair growth in people with androgenetic alopecia.
1 citations
,
June 2017 in “Journal of The American Academy of Dermatology” PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.
1 citations
,
January 2005 in “Side effects of drugs annual” The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.
April 2026 in “Dermatology and Therapy” TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.
November 2025 in “Revista Multidisciplinar do Nordeste Mineiro” Rosemary oil can help hair growth and is as effective as some traditional treatments but with fewer side effects.
September 2025 in “International Journal of Innovative Technologies in Social Science” Red light therapy may help rejuvenate skin and regrow hair.
April 2025 in “Revista de Ciências da Saúde Nova Esperança” Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.
February 2025 in “Journal of Investigative Dermatology” DMG-Na may help reduce hair loss and improve hair growth, but more research is needed.
January 2025 in “Journal of Cutaneous and Aesthetic Surgery” Low-level laser therapy effectively improves hair growth in androgenetic alopecia with minimal side effects.
January 2025 in “Journal of Aesthetic Nursing” Microneedling works better when combined with other treatments.
January 2025 in “Faculty of 1000 Research Ltd” Plant-based treatments may help reduce BPH symptoms, but more research is needed.
December 2024 in “Skin Appendage Disorders” Non-prescription products can help manage androgenic alopecia.
August 2024 in “Cosmetics” Personalized treatments for hair loss are becoming more effective by using genetic information.
The document reviews the use of minoxidil for treating androgenetic alopecia (AGA), focusing on its efficacy and safety in women. It analyzes 8 articles and finds that low-dose oral minoxidil (0.25 to 5 mg/day) is effective and generally well-tolerated, with mild side effects like hypertrichosis. Oral minoxidil may be as effective as topical solutions, offering a convenient alternative for those who do not respond well to topical treatments. A study showed that 70% of women with AGA improved with 1 mg oral minoxidil compared to 46% with 5% topical minoxidil. Despite not being FDA-approved, oral minoxidil shows promise, but further studies are needed to determine the optimal dosage and long-term safety.
June 2024 in “International Journal of Health Science” Current treatments for androgenetic alopecia are often ineffective and have side effects, needing better options.
Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.
November 2023 in “Current Dermatology Reports” Oral minoxidil is effective for various hair loss types and may improve male sexual function, but aspirin can reduce its effectiveness.
June 2023 in “Fundamental & clinical pharmacology” JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.
April 2023 in “Journal of Investigative Dermatology” Cryotherapy might help regrow hair in Alopecia Areata, but more consistent research is needed.
January 2023 in “DIGITAL HEALTH” Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.
October 2020 in “Veterinary Dermatology” New treatments and diagnostic methods for various animal skin conditions showed promising results.
Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.